National Heart, Lung, and Blood Institute; Notice of Meeting, 52916 [2021-20584]
Download as PDF
<![CDATA[
52916
Federal Register / Vol. 86, No. 182 / Thursday, September 23, 2021 / Notices
Date: October 24–26, 2021.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nina F. Schor, MD, Ph.D.,
Deputy Director, National Institute of
Neurological Disorders and Stroke, NIH,
Building 31, Room 8A52, Bethesda, MD
20892, 301–496–9746, nina.schor@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: September 17, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20580 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Heart, Lung,
and Blood Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: October 26, 2021.
Closed: 10:00 a.m. to 11:00 a.m.
Agenda: To Review and Evaluate Grant
Applications.
Place: National Institutes of Health,
Rockledge 1, 6705 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Open: 11:30 a.m. to 5:00 p.m.
Agenda: To Discuss Program Policies and
Issues.
Place: National Institutes of Health,
Rockledge 1,6705 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Virtual Access: The meeting will be
videocast and can be accessed from the NIH
Videocast. https://www.nhlbi.nih.gov/about/
advisory-and-peer-review-committees/
advisory-council. Please note, the link to the
videocast meeting will be posted within a
week of the meeting date.
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
VerDate Sep<11>2014
17:19 Sep 22, 2021
Jkt 253001
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 206–Q, Bethesda, MD
20892, 301–827–5517, moenl@mail.nih.gov
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20584 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; SEP Limited Competition:
Clinical and Translational Science Award
(CTSA) Consortium-Wide Centers: Resources
for Rapid Demonstration and Dissemination
(U24 Clinical Trials Not Allowed).
Date: October 20, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20817, (301) 435–0813,
henriquv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: September 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20582 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploratory Studies to Investigate
Mechanisms of HIV Infection, Replication,
Latency, and/or Pathogenesis in the Context
of Substance Use Disorders (R61/R33—
Clinical Trial Not Allowed).
Date: October 26, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 86, Number 182 (Thursday, September 23, 2021)]
[Notices]
[Page 52916]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20584]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Heart,
Lung, and Blood Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: October 26, 2021.
Closed: 10:00 a.m. to 11:00 a.m.
Agenda: To Review and Evaluate Grant Applications.
Place: National Institutes of Health, Rockledge 1, 6705
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Open: 11:30 a.m. to 5:00 p.m.
Agenda: To Discuss Program Policies and Issues.
Place: National Institutes of Health, Rockledge 1,6705 Rockledge
Dr., Bethesda, MD 20892 (Virtual Meeting).
Virtual Access: The meeting will be videocast and can be
accessed from the NIH Videocast. https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council. Please note,
the link to the videocast meeting will be posted within a week of
the meeting date.
Contact Person: Laura K. Moen, Ph.D., Director, Division of
Extramural Research Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
206-Q, Bethesda, MD 20892, 301-827-5517, [email protected]
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/nhlbac/index.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 17, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20584 Filed 9-22-21; 8:45 am]
BILLING CODE 4140-01-P
